Nipple aspirate fluid cytology in breast carcinoma

Cancer

Volumn 99, Issue 2, 2003, Pages 97-104

  Krishnamurthy, Savitri ^a   Sneige, Nour ^a   Thompson, Patricia A ^b   Marcy, Sylvie M ^a   Singletary, S Eva ^a   Cristofanilli, Massimo ^a   Hunt, Kelly K ^a   Kuerer, Henry M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Breast carcinoma; Cytology; Histologic correlations; Nipple aspirate fluid

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION CYTOLOGY; BREAST CARCINOMA; BREAST DISCHARGE; BREAST PAPILLOMA; CANCER CHEMOTHERAPY; CARCINOMA IN SITU; CELL COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MACROPHAGE; MASSAGE; NIPPLE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL;

ADULT; AGED; BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, PAPILLARY; EPITHELIAL CELLS; FEMALE; HUMANS; MIDDLE AGED; NIPPLES; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0038409999     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10958     Document Type: Article

References (17)

1. Papanicolaou GN, Holmquist DG, Bader GM, Falk EA. Exfoliative cytology of the human mammary gland and its value in the diagnosis of cancer and other diseases of the breast. Cancer. 1958;11:377-409.
2. Petrakis NL, Mason L, Lee R. Association of role, age, menopausal status and cerumen type with breast fluid secretion in nonlactating women, as determined by nipple aspiration. J Natt Cancer Inst. 1975;54:829-834.
3. Sartorius OW, Smith HS, Morris P, Benedict BD, Friesen L. Cytologic evaluation of breast fluid in the detection of breast disease. Natt Cancer Inst. 1977;59:1073-1079.
4. Berehring GC. Screening for breast atypias using exfoliative cytology. Cancer. 1979;43:1788-1799.
5. Wynder EL, Lahti H, Laakso K, Cheng S, DeBevoise S, rose DP. Nipple aspirates of breast fluid and the epidemiology of breast disease. Cancer. 1985;56:1473-1478.
6. Petrakis NL, Wrensch MR, Ernster VL, Miike R, King EB, Boodson WH. Prognostic significance of atypical epithelial hyperplasia in nipple aspirate of breast fluid. Lancet. 1987;2:505.
7. Petrakis NL. Physiologic, biochemical and cytologic aspects of nipple aspirate fluid. Breast Cancer Res Treat. 1986;8:7-19.
8. King EB, Chew KL, Petrakis NL, Ernsten VL. Nipple aspirate cytology for the study of breast cancer precursors. J Natl Cancer Inst. 1983;71:1115-1118.
9. Wrensch MR, Petrakis NL, Gruenke LD, et al. Factors associated with obtaining nipple aspirate fluid. Breast Cancer Res Treat. 1990;15:39-51.
10. Wrench MW, Petrakis NL, King EB, et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am J Epidemiol. 1992;135:130-141.
11. Wrensch MW, Petrakis NL, King EB, Lee MM, Miike R. Breast cancer risk associated with abnormal cytology in nipple aspirates of breast biopsy. Am J Epidemiol. 1993;137:829-833.
12. Sauter ER, Ross E, Daly M, et al. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer. 1997;76:494-501.
13. Sauter ER, Ehya H, Babb T, et al. Biologic markers of risk in nipple aspirate fluid are associated with residual cancer and tumor size. Br J Cancer. 1999;81:1222-1227.
14. Wrensch MR, Petrakis NL, Miike R, et al. Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natt Cancer Inst. 2001;93:1791-1798.
15. The uniform approach to breast fine needle aspiration biopsy. NIH consensus development conference. Am J Surg. 1997;174:371-385.
16. Venables WN, Ripley BD. Modern applied statistics with Splus. 3rd ed. New York: Springer, 1999.
17. King EB, Barrett D, King MC, Petrakis NL. Cellular composition of the nipple aspirate specimen of breast fluid: 1. The benign cells. Am J Clin Pathol. 1975;64:728-738.